PL1872783T3 - Środek leczniczy w schorzeniach rogówkowo-spojówkowych - Google Patents

Środek leczniczy w schorzeniach rogówkowo-spojówkowych

Info

Publication number
PL1872783T3
PL1872783T3 PL06732190T PL06732190T PL1872783T3 PL 1872783 T3 PL1872783 T3 PL 1872783T3 PL 06732190 T PL06732190 T PL 06732190T PL 06732190 T PL06732190 T PL 06732190T PL 1872783 T3 PL1872783 T3 PL 1872783T3
Authority
PL
Poland
Prior art keywords
corneal
therapeutic agent
conjunctival disorder
conjunctival
disorder
Prior art date
Application number
PL06732190T
Other languages
English (en)
Inventor
Keiichi Shibagaki
Shin-Ichiro Hirai
Masatsugu Nakamura
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of PL1872783T3 publication Critical patent/PL1872783T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL06732190T 2005-04-21 2006-04-21 Środek leczniczy w schorzeniach rogówkowo-spojówkowych PL1872783T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005123791 2005-04-21
EP06732190A EP1872783B1 (en) 2005-04-21 2006-04-21 Therapeutic agent for corneal/conjunctival disorder
PCT/JP2006/308382 WO2006115185A1 (ja) 2005-04-21 2006-04-21 角結膜障害治療剤

Publications (1)

Publication Number Publication Date
PL1872783T3 true PL1872783T3 (pl) 2012-05-31

Family

ID=37214801

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06732190T PL1872783T3 (pl) 2005-04-21 2006-04-21 Środek leczniczy w schorzeniach rogówkowo-spojówkowych

Country Status (12)

Country Link
US (1) US20090042962A1 (pl)
EP (1) EP1872783B1 (pl)
KR (1) KR20070121791A (pl)
CN (1) CN101163474B (pl)
CA (1) CA2605306A1 (pl)
DK (1) DK1872783T3 (pl)
ES (1) ES2379580T3 (pl)
NO (1) NO20075980L (pl)
PL (1) PL1872783T3 (pl)
PT (1) PT1872783E (pl)
RU (1) RU2420280C2 (pl)
WO (1) WO2006115185A1 (pl)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
DE3928177A1 (de) * 1989-04-08 1991-02-28 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
EP0400835A1 (en) * 1989-05-15 1990-12-05 Merck & Co. Inc. Substituted benzimidazoles as angiotensin II antagonists
CZ154994A3 (en) * 1993-07-02 1995-09-13 Senju Pharma Co Visual hypotensive agent
JPH0867674A (ja) * 1993-07-02 1996-03-12 Senju Pharmaceut Co Ltd 眼圧降下剤
ATE300287T1 (de) * 1994-02-08 2005-08-15 Novartis Pharma Gmbh Behandlung von normaldruckglaukom mit valsartan
WO1996040255A2 (en) * 1995-06-07 1996-12-19 G.D. Searle & Co. Method to treat cardiofibrosis with a combination therapy of an angiotensin ii antagonist and an epoxy-steroidal aldosterone antagonist
GB9604926D0 (en) * 1996-03-08 1996-05-08 Sandoz Ltd Organic compounds
JPH10218792A (ja) * 1997-02-12 1998-08-18 Santen Pharmaceut Co Ltd アンギオテンシン変換酵素阻害薬を有効成分とする涙液分泌促進および角結膜障害治療剤
CA2326222C (en) * 1998-04-27 2008-09-23 Fujisawa Pharmaceutical Co., Ltd. Medicinal compositions
JP2000143650A (ja) * 1998-11-13 2000-05-26 Takeda Chem Ind Ltd 新規チアゾリジン誘導体、その製造法および用途
ATE289204T1 (de) * 1999-04-28 2005-03-15 Takeda Pharmaceutical Arzneimittel zur vorbeugung / behandlung / inhibierung des fortschritts für einfache oder preproliferative retinopathie
JP3790093B2 (ja) * 1999-06-11 2006-06-28 三共株式会社 局所投与用眼圧低下組成物
ATE295721T1 (de) * 1999-06-11 2005-06-15 Sankyo Co Den augendruck senkende zusammensetzung zur topischen anwendung
EP1369130A1 (en) * 2001-03-16 2003-12-10 Takeda Chemical Industries, Ltd. Process for producing sustained release preparation
EG24716A (en) * 2002-05-17 2010-06-07 Novartis Ag Combination of organic compounds
US7232828B2 (en) * 2002-08-10 2007-06-19 Bethesda Pharmaceuticals, Inc. PPAR Ligands that do not cause fluid retention, edema or congestive heart failure

Also Published As

Publication number Publication date
KR20070121791A (ko) 2007-12-27
EP1872783A4 (en) 2009-07-29
EP1872783A1 (en) 2008-01-02
WO2006115185A1 (ja) 2006-11-02
RU2420280C2 (ru) 2011-06-10
CN101163474B (zh) 2012-02-22
EP1872783B1 (en) 2011-12-28
ES2379580T3 (es) 2012-04-27
CA2605306A1 (en) 2006-11-02
RU2007143054A (ru) 2009-05-27
US20090042962A1 (en) 2009-02-12
NO20075980L (no) 2008-01-17
PT1872783E (pt) 2012-01-16
CN101163474A (zh) 2008-04-16
DK1872783T3 (da) 2012-04-23

Similar Documents

Publication Publication Date Title
IL185250A0 (en) Microimplants for ocular administration
GB0506147D0 (en) Therapeutic agents
GB0521139D0 (en) Therapeutic agent
GB0516091D0 (en) Therapeutic agent
EP2060264A4 (en) AGENT FOR TREATING OCULAR DISEASES
GB0519797D0 (en) Therapeutic agents
SI1884234T1 (sl) Profilaktično ali terapevtsko sredstvo za kornealno in konjunktivalno motnjo
GB0505725D0 (en) Therapeutic agents
GB0505437D0 (en) Therapeutic agents
GB0519350D0 (en) Therapeutic agents
GB0518819D0 (en) Therapeutic agents
GB0518817D0 (en) Therapeutic agents
GB0516661D0 (en) Therapeutic agents
GB0514738D0 (en) Therapeutic agents
EP1844792A4 (en) THERAPEUTIC AGENT AGAINST OBSTIPATION
EP1859795A4 (en) THERAPEUTIC AGENT FOR OPHTHALMIC DISEASES
PL1876175T3 (pl) Środek terapeutyczny do leczenia chorób rogówki
EP1958949A4 (en) THERAPEUTIC AGENT AGAINST HORNHAUT / BINDEHAUT DISEASE
PL1872783T3 (pl) Środek leczniczy w schorzeniach rogówkowo-spojówkowych
EP1810673A4 (en) THERAPEUTIC AGENT FOR SUB-MUCOUS INTERSTITIAL CYSTOPATHY
GB0523998D0 (en) Therapeutic agents
EP1757603A4 (en) THERAPEUTIC AGENT FOR KERAATOCONJUNCTIVITIS AFFECTION
EP1900363A4 (en) THERAPEUTIC AGENT AGAINST PAIN
GB0508153D0 (en) Therapeutic agent
PL1927353T3 (pl) Środek leczniczy na dolegliwości rogówki